Lumiracoxib
Lumiracoxib (Prexige) is a highly selective COX-2 inhibitor, demonstrating potent activity with an IC50 of 0.14 μM and over 500-fold selectivity versus COX-1. This compound has been utilized in research models to investigate inflammation, pain pathways, and cardiovascular effects in both cellular and animal studies.
Product Specifications
CAS Number
220991-20-8
Product Name Alternative
Prexige, bone cancer, Cyclooxygenase, COX, COX 189, COX-1, COX189, COX-189, COX-2, Lumiracoxib, Metabolic Syndrome, osteoarthritis, inflammatory, inhibit, Inhibitor, hyperalgesic
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
96.64% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:55 mg/mL (187.25 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.81 mM)
Smiles
N (C1=C (CC (O) =O) C=C (C) C=C1) C2=C (Cl) C=CC=C2F
Molecular Formula
C15H13ClFNO2
Molecular Weight
293.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EKL62455 96 Tests
Human Major Histocompatibility Complex Class I G (MHCG) ELISA Kit
Sign In for Pricing
View Details 
436853-01 10 mg
5-Methoxy-4- (phenylmethoxy) -1H-indole-3-acetonitrile
Sign In for Pricing
View Details 436853-02 100 mg
5-Methoxy-4- (phenylmethoxy) -1H-indole-3-acetonitrile
Sign In for Pricing
View Details 